You are here:
Biotech & Pharma — Patented Technologies
Last Updated:February 26, 2026
About This Investor
JP-B-648
With roots in Japan, this investor is building pipeline coverage and invites relevant teasers. M&A rationale centers on Expand existing businesses overseas. They are specifically targeting: Manufacturing of eye care, skin care products, oral medications, and regenerative medicine – related products Only companies of a certain size and with patents or special technologies will be…
Biotech / Pharmaceuticals
Worldwide
Overseas Expansion
$130.8M - $654.2M
Majority/100% | Minority ok if step-up to majority feasible
Request Full Investor Profile
Similar Investors
JP-B-665
They can deploy approximately $654K – $6.54M for the right
Construction & IT
ASEAN
Overseas Expansion
$654K - $6.54M
Minority / Majority / 100%
JP-B-39
They are looking for opportunities aligned with the following target
Information Technology
Asia, Worldwide
Strategic Expansion
$52.3M - $98.1M (IT - related companies with sales of 10 billion yen or more (considerable))
Minority / Majority / 100% | Revenue ≥ USD 65M (USD 65.3M) | Growth IT venture: minority ok
JP-B-437
Geographic and deal conditions are important for this mandate: Singapore,
Information Technology
Australia, Malaysia, Singapore, Thailand
Strategic Expansion
$13.1M - $196.3M
Majority / 100% | Revenue ≥ USD 9.8M | Profitable